Roivant is a New York-based biotechnology company that researches and develops novel therapies for the treatment of neurological and endocrine diseases.
Business Model:
Revenue: $18.9M
Employees: 501-1,000
Address: 151 W 42nd Street
City: New York
State: NY
Zip: 10036
Country: US
Roivant is a New York-based biotechnology company that researches and develops novel therapies for the treatment of neurological and endocrine diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/1/2021
IPO Valuation:
$7B
Ticker Symbol:
ROIV
Amount Raised:
$611M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
10/2017 | Arbutus Biopharma | Post-IPO Equity | 116.4M |
4/2018 | Datavant | Equity | 40.5M |
12/2022 | Lokavant | Series A | 21M |
11/2021 | gen-t | Pre Seed Round | 2M |
10/2020 | Datavant | Series B | 40M |
8/2021 | Immunovant | Corporate Round | 200M |
11/2021 | Medallion | Series B | 0 |
11/2021 | Medallion | Series B | 0 |
11/2021 | gen-t | Pre Seed Round | 0 |
8/2021 | Immunovant | Post-IPO Equity | 0 |
10/2020 | Datavant | Series B | 0 |
4/2018 | Datavant | Venture Round | 0 |
10/2017 | Arbutus Biopharma | Post-IPO Equity | 0 |
Announced Date | Name | Price |
---|---|---|
2/2021 | Silicon Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|